PRESS RELEASE
26 June 2026

Mintz Advises On MoonLake Immunotherapeutics’ $200 Million Public Offering

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Mintz advised the underwriters in connection with MoonLake Immunotherapeutics’ $200 million public offering of Class A ordinary shares.
United States

Mintz advised the underwriters in connection with MoonLake Immunotherapeutics’ $200 million public offering of Class A ordinary shares.

Leerink Partners, Guggenheim Securities, Cantor and LifeSci Capital acted as joint bookrunning managers for the offering. H.C. Wainwright & Co. and Clear Street acted as lead managers for the offering.

The Mintz capital markets team included William Hicks, John Rudy, Nishant Dharia, Jocelyn Sun, and Paty Garza-Gonzalez. Terri Shieh-Newton assisted with intellectual property matters and Joanne Hawana assisted with regulatory matters. Members of the Mintz team are based in the Boston, New York, San Diego, San Francisco and Washington, DC offices.

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More